A detailed history of First Horizon Advisors, Inc. transactions in Innoviva, Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 285 shares of INVA stock, worth $5,030. This represents 0.0% of its overall portfolio holdings.

Number of Shares
285
Previous 223 27.8%
Holding current value
$5,030
Previous $3,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$16.33 - $20.04 $1,012 - $1,242
62 Added 27.8%
285 $5,000
Q2 2024

Jul 19, 2024

BUY
$14.4 - $16.4 $3,211 - $3,657
223 New
223 $3,000
Q2 2023

Aug 03, 2023

SELL
$11.39 - $13.72 $1,321 - $1,591
-116 Reduced 65.54%
61 $0
Q1 2023

May 15, 2023

SELL
$10.73 - $13.6 $579 - $734
-54 Reduced 23.38%
177 $1,000
Q2 2022

Aug 02, 2022

BUY
$14.32 - $19.88 $3,307 - $4,592
231 New
231 $3,000
Q1 2022

May 10, 2022

SELL
$15.39 - $20.25 $3,555 - $4,677
-231 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$13.06 - $17.24 $2,807 - $3,706
215 Added 1343.75%
231 $3,000
Q3 2021

Nov 09, 2021

SELL
$13.06 - $17.24 $2,154 - $2,844
-165 Reduced 91.16%
16 $0
Q2 2021

Aug 09, 2021

BUY
$11.45 - $13.96 $583 - $711
51 Added 39.23%
181 $2,000
Q1 2021

May 11, 2021

BUY
$11.06 - $12.87 $1,437 - $1,673
130 New
130 $1,000
Q3 2019

Oct 23, 2019

SELL
$10.05 - $14.55 $1,175 - $1,702
-117 Closed
0 $0
Q2 2019

Aug 05, 2019

SELL
$13.1 - $14.95 $930 - $1,061
-71 Reduced 37.77%
117 $0
Q1 2019

Apr 26, 2019

BUY
$13.69 - $20.06 $2,573 - $3,771
188 New
188 $0

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.23B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.